Blackhall Leslie J, Read Paul, Stukenborg George, Dillon Patrick, Barclay Joshua, Romano Andrew, Harrison James
1 Department of Palliative Care, University of Virginia , Charlottesville, Virginia.
2 Department of Internal Medicine, University of Virginia , Charlottesville, Virginia.
J Palliat Med. 2016 Jan;19(1):57-63. doi: 10.1089/jpm.2015.0272. Epub 2015 Dec 1.
Studies suggest that outpatient palliative care can reduce hospitalization and increase hospice utilization for patients with cancer, however there are insufficient resources to provide palliative care to all patients from time of diagnosis. It is also unclear whether inpatient consultation alone provides similar benefits. A better understanding of the timing, setting, and impact of palliative care for patients with cancer is needed.
The purpose of this study was to measure timing of referral to outpatient palliative care and impact on end-of-life (EOL) care.
The Comprehensive Assessment with Rapid Evaluation and Treatment (CARE Track) program is a phased intervention integrating outpatient palliative care into cancer care. In Year 1 patients were referred at the discretion of their oncologist.
Academic medical center.
We compared EOL hospitalization, hospice utilization, and costs of care for CARE Track patients compared to those never seen by palliative care or seen only in hospital.
Patients were referred a median of 72.5 days prior to death. CARE Track patients had few hospitalizations at end of life, were less likely to die in hospital, had increased hospice utilization, and decreased costs of care; these results were significant even after controlling for differences between groups. Inpatient consultation alone did not impact these variables. However, only approximately half of patients with incurable cancers were referred to this program.
Referral outpatient palliative care within 3 months of death improved EOL care and reduced costs, benefits not seen with inpatient care only. However, many patients were never referred, and methods of systematically identifying appropriate patients are needed.
研究表明,门诊姑息治疗可以减少癌症患者的住院次数并提高临终关怀的利用率,然而,从诊断之时起就没有足够的资源为所有患者提供姑息治疗。单独的住院咨询是否能带来类似的益处也尚不清楚。需要更好地了解癌症患者姑息治疗的时机、环境和影响。
本研究的目的是衡量转介至门诊姑息治疗的时机以及对临终(EOL)护理的影响。
综合评估与快速评估及治疗(CARE Track)计划是一项分阶段干预措施,将门诊姑息治疗纳入癌症护理。在第1年,患者由其肿瘤学家酌情转介。
学术医疗中心。
我们比较了CARE Track患者与从未接受过姑息治疗或仅在医院接受过姑息治疗的患者的临终住院情况、临终关怀利用率和护理成本。
患者在死亡前中位数72.5天被转介。CARE Track患者在临终时住院次数较少,在医院死亡的可能性较小,临终关怀利用率增加,护理成本降低;即使在控制了组间差异后,这些结果仍具有显著性。仅住院咨询对这些变量没有影响。然而,只有约一半的不可治愈癌症患者被转介到该计划。
在死亡前3个月内转介至门诊姑息治疗可改善临终护理并降低成本,仅住院护理则未见此类益处。然而,许多患者从未被转介,需要系统识别合适患者的方法。